Ipca Laboratories RX
FDA Approved Drugs
Ipca Laboratories RX
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 51
- Latest Approval Date May 01, 2026
- Data Source FDA
- First Approval Date Sep 18, 2006
Company Overview
Social Profiles
Company Snapshot
Ipca Laboratories RX
Kandivli (West), Mumbai – 400 067, Maharashtra
India
www.ipca.com/ swapna.ugale@ipca.com View on MapFDA Approved Drug Records ( 51 records )
Drug Name
ALENDRONATE SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2024-06-04
Active Ingredient
ALENDRONATE SODIUM
Application Number
206387
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2024-06-04
Regulatory Status
RX
Drug Name
ALENDRONATE SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 35MG BASE
Approval Date
2024-06-04
Active Ingredient
ALENDRONATE SODIUM
Application Number
206387
Product Number
2
Dosage Form
-
Strength
EQ 35MG BASE
Approval Date
2024-06-04
Regulatory Status
RX
Drug Name
ALENDRONATE SODIUM
Product Number
3
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2024-06-04
Active Ingredient
ALENDRONATE SODIUM
Application Number
206387
Product Number
3
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2024-06-04
Regulatory Status
RX
Drug Name
ALENDRONATE SODIUM
Product Number
4
Dosage Form
-
Strength
EQ 70MG BASE
Approval Date
2024-06-04
Active Ingredient
ALENDRONATE SODIUM
Application Number
206387
Product Number
4
Dosage Form
-
Strength
EQ 70MG BASE
Approval Date
2024-06-04
Regulatory Status
RX
Drug Name
ATENOLOL
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2006-12-27
Active Ingredient
ATENOLOL
Application Number
77877
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2006-12-27
Regulatory Status
RX
Drug Name
ATENOLOL
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2006-12-27
Active Ingredient
ATENOLOL
Application Number
77877
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2006-12-27
Regulatory Status
RX
Drug Name
ATENOLOL
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2006-12-27
Active Ingredient
ATENOLOL
Application Number
77877
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2006-12-27
Regulatory Status
RX
Drug Name
BUPROPION HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2025-05-02
Active Ingredient
BUPROPION HYDROCHLORIDE
Application Number
207874
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
2025-05-02
Regulatory Status
RX
Drug Name
BUPROPION HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
2025-05-02
Active Ingredient
BUPROPION HYDROCHLORIDE
Application Number
207874
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
2025-05-02
Regulatory Status
RX
Drug Name
BUPROPION HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
200MG
Approval Date
2025-05-02
Active Ingredient
BUPROPION HYDROCHLORIDE
Application Number
207874
Product Number
3
Dosage Form
-
Strength
200MG
Approval Date
2025-05-02
Regulatory Status
RX
Drug Name
CHLORTHALIDONE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2024-11-12
Active Ingredient
CHLORTHALIDONE
Application Number
209162
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2024-11-12
Regulatory Status
RX
Drug Name
CHLORTHALIDONE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2024-11-12
Active Ingredient
CHLORTHALIDONE
Application Number
209162
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2024-11-12
Regulatory Status
RX
Drug Name
ETODOLAC
Product Number
1
Dosage Form
-
Strength
400MG
Approval Date
2024-05-01
Active Ingredient
ETODOLAC
Application Number
204729
Product Number
1
Dosage Form
-
Strength
400MG
Approval Date
2024-05-01
Regulatory Status
RX
Drug Name
ETODOLAC
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2024-05-01
Active Ingredient
ETODOLAC
Application Number
204729
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
2024-05-01
Regulatory Status
RX
Drug Name
ETODOLAC
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2024-08-01
Active Ingredient
ETODOLAC
Application Number
205448
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2024-08-01
Regulatory Status
RX
Drug Name
ETODOLAC
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2024-08-01
Active Ingredient
ETODOLAC
Application Number
205448
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
2024-08-01
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2006-09-18
Active Ingredient
FUROSEMIDE
Application Number
78010
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
2006-09-18
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
2006-09-18
Active Ingredient
FUROSEMIDE
Application Number
78010
Product Number
2
Dosage Form
-
Strength
40MG
Approval Date
2006-09-18
Regulatory Status
RX
Drug Name
FUROSEMIDE
Product Number
3
Dosage Form
-
Strength
80MG
Approval Date
2006-09-18
Active Ingredient
FUROSEMIDE
Application Number
78010
Product Number
3
Dosage Form
-
Strength
80MG
Approval Date
2006-09-18
Regulatory Status
RX
Drug Name
HYDROXYCHLOROQUINE SULFATE
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2007-06-14
Active Ingredient
HYDROXYCHLOROQUINE SULFATE
Application Number
40766
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
2007-06-14
Regulatory Status
RX
Drug Name
METOCLOPRAMIDE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2008-06-12
Active Ingredient
METOCLOPRAMIDE HYDROCHLORIDE
Application Number
78807
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2008-06-12
Regulatory Status
RX
Drug Name
METOCLOPRAMIDE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2008-06-12
Active Ingredient
METOCLOPRAMIDE HYDROCHLORIDE
Application Number
78807
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2008-06-12
Regulatory Status
RX
Drug Name
METOPROLOL SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 25MG TARTRATE
Approval Date
2025-06-25
Active Ingredient
METOPROLOL SUCCINATE
Application Number
206980
Product Number
1
Dosage Form
-
Strength
EQ 25MG TARTRATE
Approval Date
2025-06-25
Regulatory Status
RX
Drug Name
METOPROLOL SUCCINATE
Product Number
2
Dosage Form
-
Strength
EQ 50MG TARTRATE
Approval Date
2025-06-25
Active Ingredient
METOPROLOL SUCCINATE
Application Number
206980
Product Number
2
Dosage Form
-
Strength
EQ 50MG TARTRATE
Approval Date
2025-06-25
Regulatory Status
RX
Drug Name
METOPROLOL SUCCINATE
Product Number
3
Dosage Form
-
Strength
EQ 100MG TARTRATE
Approval Date
2025-06-25
Active Ingredient
METOPROLOL SUCCINATE
Application Number
206980
Product Number
3
Dosage Form
-
Strength
EQ 100MG TARTRATE
Approval Date
2025-06-25
Regulatory Status
RX
Drug Name
METOPROLOL SUCCINATE
Product Number
4
Dosage Form
-
Strength
EQ 200MG TARTRATE
Approval Date
2025-06-25
Active Ingredient
METOPROLOL SUCCINATE
Application Number
206980
Product Number
4
Dosage Form
-
Strength
EQ 200MG TARTRATE
Approval Date
2025-06-25
Regulatory Status
RX
Drug Name
METOPROLOL TARTRATE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2008-06-17
Active Ingredient
METOPROLOL TARTRATE
Application Number
78459
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2008-06-17
Regulatory Status
RX
Drug Name
METOPROLOL TARTRATE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2008-06-17
Active Ingredient
METOPROLOL TARTRATE
Application Number
78459
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2008-06-17
Regulatory Status
RX
Drug Name
METOPROLOL TARTRATE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2008-06-17
Active Ingredient
METOPROLOL TARTRATE
Application Number
78459
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2008-06-17
Regulatory Status
RX
Drug Name
ONDANSETRON
Product Number
1
Dosage Form
-
Strength
4MG
Approval Date
2023-10-30
Active Ingredient
ONDANSETRON
Application Number
209389
Product Number
1
Dosage Form
-
Strength
4MG
Approval Date
2023-10-30
Regulatory Status
RX
Drug Name
ONDANSETRON
Product Number
2
Dosage Form
-
Strength
8MG
Approval Date
2023-10-30
Active Ingredient
ONDANSETRON
Application Number
209389
Product Number
2
Dosage Form
-
Strength
8MG
Approval Date
2023-10-30
Regulatory Status
RX
Drug Name
ONDANSETRON HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2014-01-23
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
203761
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2014-01-23
Regulatory Status
RX
Drug Name
ONDANSETRON HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE
Approval Date
2014-01-23
Active Ingredient
ONDANSETRON HYDROCHLORIDE
Application Number
203761
Product Number
2
Dosage Form
-
Strength
EQ 8MG BASE
Approval Date
2014-01-23
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2008-06-02
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
78955
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2008-06-02
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2008-06-02
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
78955
Product Number
2
Dosage Form
-
Strength
20MG
Approval Date
2008-06-02
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2008-06-02
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
78955
Product Number
3
Dosage Form
-
Strength
40MG
Approval Date
2008-06-02
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
60MG
Approval Date
2008-06-02
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
78955
Product Number
4
Dosage Form
-
Strength
60MG
Approval Date
2008-06-02
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
80MG
Approval Date
2008-06-02
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
78955
Product Number
5
Dosage Form
-
Strength
80MG
Approval Date
2008-06-02
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2026-05-01
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
203103
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
2026-05-01
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
80MG
Approval Date
2026-05-01
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
203103
Product Number
2
Dosage Form
-
Strength
80MG
Approval Date
2026-05-01
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
120MG
Approval Date
2026-05-01
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
203103
Product Number
3
Dosage Form
-
Strength
120MG
Approval Date
2026-05-01
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
160MG
Approval Date
2026-05-01
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
203103
Product Number
4
Dosage Form
-
Strength
160MG
Approval Date
2026-05-01
Regulatory Status
RX
Drug Name
RISPERIDONE
Product Number
1
Dosage Form
-
Strength
0.25MG
Approval Date
2024-06-26
Active Ingredient
RISPERIDONE
Application Number
205104
Product Number
1
Dosage Form
-
Strength
0.25MG
Approval Date
2024-06-26
Regulatory Status
RX
Drug Name
RISPERIDONE
Product Number
2
Dosage Form
-
Strength
0.5MG
Approval Date
2024-06-26
Active Ingredient
RISPERIDONE
Application Number
205104
Product Number
2
Dosage Form
-
Strength
0.5MG
Approval Date
2024-06-26
Regulatory Status
RX
Drug Name
RISPERIDONE
Product Number
3
Dosage Form
-
Strength
1MG
Approval Date
2024-06-26
Active Ingredient
RISPERIDONE
Application Number
205104
Product Number
3
Dosage Form
-
Strength
1MG
Approval Date
2024-06-26
Regulatory Status
RX
Drug Name
RISPERIDONE
Product Number
4
Dosage Form
-
Strength
2MG
Approval Date
2024-06-26
Active Ingredient
RISPERIDONE
Application Number
205104
Product Number
4
Dosage Form
-
Strength
2MG
Approval Date
2024-06-26
Regulatory Status
RX
Drug Name
RISPERIDONE
Product Number
5
Dosage Form
-
Strength
3MG
Approval Date
2024-06-26
Active Ingredient
RISPERIDONE
Application Number
205104
Product Number
5
Dosage Form
-
Strength
3MG
Approval Date
2024-06-26
Regulatory Status
RX
Drug Name
RISPERIDONE
Product Number
6
Dosage Form
-
Strength
4MG
Approval Date
2024-06-26
Active Ingredient
RISPERIDONE
Application Number
205104
Product Number
6
Dosage Form
-
Strength
4MG
Approval Date
2024-06-26
Regulatory Status
RX
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2025-07-15
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
206019
Product Number
1
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2025-07-15
Regulatory Status
RX
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2025-07-15
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
206019
Product Number
2
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2025-07-15
Regulatory Status
RX
Drug Name
SUMATRIPTAN SUCCINATE
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2025-07-15
Active Ingredient
SUMATRIPTAN SUCCINATE
Application Number
206019
Product Number
3
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2025-07-15
Regulatory Status
RX
Drug Status Breakdown
51 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ALENDRONATE SODIUM
Application Number
206387
Product Number
1
Active Ingredient
ALENDRONATE SODIUM
Dosage Form
-
Strength
EQ 10MG BASE
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.